Results 171 to 180 of about 112,050 (329)

L-deprenyl, A Selective MAO-B Inhibitor [PDF]

open access: yes, 2011
Monoamine oxidase inhibitors (MAOIs) are now recognized as effective medications in the treatment of major depression (1). However, their clinical use has been limited by the risk of severe hypertensive reactions to oral tyramine challenge. Prevention of
Lam, MD, Raymond W.
core   +1 more source

Development of a New Class of Monoamine Oxidase-B Inhibitors by Fine-Tuning the Halogens on the Acylhydrazones. [PDF]

open access: yesACS Omega, 2023
Jayan J   +11 more
europepmc   +1 more source

Hallucinogens: mechanisms and medical complications [PDF]

open access: yes, 2013
Thesis (M.A.)--Boston UniversityHallucinogens are drugs that alter consciousness by distorting primarily auditory and visual perception but they can affect any sensory system. Hallucinogens also affect judgment, orientation, memory, or emotion.
Chan, Ryan Harry Alexander
core   +1 more source

α‐Synuclein stimulation of monoamine oxidase‐B and legumain protease mediates the pathology of Parkinson's disease

open access: yesEMBO Journal, 2018
S. Kang   +9 more
semanticscholar   +1 more source

Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer's disease. [PDF]

open access: yesJ Enzyme Inhib Med Chem, 2023
Zhang C   +9 more
europepmc   +1 more source

Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease

open access: green, 2019
Changjun Zhang   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy